---
figid: PMC10527181__cancers-15-04632-g003
pmcid: PMC10527181
image_filename: cancers-15-04632-g003.jpg
figure_link: /pmc/articles/PMC10527181/figure/cancers-15-04632-f003/
number: Figure 3
figure_title: ''
caption: 'Immune checkpoint inhibitors targeting the PD-1:PD-L1 pathway in advanced,
  recurrent EC: summary of strengths, weaknesses, opportunities, and threats (SWOT).'
article_title: 'Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced,
  Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis.'
citation: Racheal Louise Johnson, et al. Cancers (Basel). 2023 Sep;15(18):4632.
year: '2023'

doi: 10.3390/cancers15184632
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- endometrial cancer
- immunotherapy
- PD-1
- PD-L1
- lenvatinib

---
